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either sex. Future studies should elucidate possible mechanisms of
actions.
http://dx.doi.org/10.1016/j.maturitas.2017.06.009
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Introduction: Training status and sex hormones inﬂuence the
cardiovascular response to orthostatic stress. The aim of this study
was to investigate the impact ofmenopausal status on left ventricu-
lar (LV) function and rotational mechanics in response to exercise
training and lower body negative pressure (LBNP).
Methods: Twenty-ﬁve healthy untrained middle-aged women
(age45–58years;11pre-menopausal [Pre-M], 14post-menopausal
[Post-M]) completed 12 weeks of exercise training (3 ses-
sions/week consisting of 4×4min intervals at 90–95% maximum
heart rate). Blood volume was assessed via CO-rebreathing, and
maximal aerobic capacity was measured on an upright cycle
ergometer before and after exercise training. LV function was
assessed via echocardiography at 0, −15 and −30mmHg LBNP.
Results and Discussion: Peak power output and maximal
aerobic capacity increased after exercise training (P<0.01), but
this increase was greater in pre- than post-menopausal women
(mean± SD; Pre-M before 147±29 vs. after 179±28, Post-M
before 145±26 vs. after 169±24W; Pre-M before 29±5 vs.
after 37±5, Post-M before 29±6 vs. after 34±5mL/min/kg;
respectively, both P<0.05). Blood volume increased after exercise
training in pre- and post-menopausal women (P=0.04), result-
ing in a smaller decrease in end-diastolic volume during LBNP
(LBNP× training P=0.06). This enhanced LV ﬁlling after exercise
training was further evidenced by higher peak trans-mitral ﬁlling
velocities in early diastole both at rest and during LBNP (train-
ing P<0.01). Cardiac output in pre-menopausal women during
LBNP was underpinned by higher heart rates and greater peak
twist, systolic twisting velocity and basal rotational mechanics,
comparedwith post-menopausalwomen (menopause interactions
P<0.1).
Conclusion: Pre-menopausal women show a greater aerobic
adaptability to exercise training than post-menopausal women,
and rely more on acute cardiac responses to cope with low levels
of orthostatic stress.
http://dx.doi.org/10.1016/j.maturitas.2017.06.010
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Background: Some studies have shown that testosterone (T)
therapy is associatedwith an increase in venous thrombotic events,
particularly in men at high risk. This may be due to aromatization
of T and subsequent estrogen induced thrombophilia.
Subcutaneous (SC) T implants bypass the liver and do not
adversely affect the clotting system. However, T increases renal
erythropoietin andstimulates thebonemarrow increasingerythro-
cyte production. Elevated Estradiol (E2) is also associated with an
increase in hematocrit (Hct) in men.
Methods: 344 adult male patients were accrued March 2013-
2017 to an IRB approved chart review study investigating the
occurrence of cardiac and prostate events in men treated with SC T,
or T combined with anastrozole (A) in the implant. A is prescribed
to prevent excess aromatization to E2.
Serum T and E2 levels were measured 4 weeks after insertion
and/or at the end of the cycle when the patient became symp-
tomatic. Hb and Hct were monitored. Mean age at ﬁrst insert was
52.9±9.8 y. Mean age at the time of analysis was 57.7±10.5 y.
Mean length of therapy at the time of analysis was 4.8±3.1 years,
range 0.17- 11.6 y.
Results: 98.5% (339/344) of men treated during this time
period received A in combination with T. Mean T dose was
1878±263mg. Mean SC A dose was 14.8±3.9mg with the major-
ity of men receiving 16mg. Mean 4 week T level on therapy was
1235±313ng/dl. Mean E2 at week 4 was 16.45±11.73pg/ml.
Mean T level when symptoms returned was 586±248ng/dl. Mean
E2 was 18.65±11.78pg/ml. Mean Hb on therapy was 16.3±1.33
and mean Hct was 48.5±4.0.
There have been no episodes of venous thrombosis or throm-
boembolic events in 344 men treated with T+A implants in over
1600 person-years of therapy. This compares favorably to an
expected annual incidence of 149/100 000 (1.5/1000) for males age
55-59 y.
Conclusion: SC T+A implant therapy does not increase andmay
lower the occurrence of venous thrombotic events.
http://dx.doi.org/10.1016/j.maturitas.2017.06.011
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Background: Little is known about the distribution of activity
over the 24-hour spectrum in late old age and its association with
demographic and health factors. We aimed to evaluate the distri-
bution of physical activity (PA), sedentary behavior and sleep and
associated factors in the elderly population.
Methods: Our study included 1210 participants (51.9% women)
aged 70-94 years (mean age 77.5 years, standard deviation (SD):
5.0) fromthepopulation-basedRotterdamStudy. Participantswore
a triaxial accelerometer (GeneActiv) around the wrist for 7 days,
between July 2014 and June 2016. We examined if PA, sedentary
behavior and sleep differed by age, sex, body mass index (BMI),
smoking status, alcohol consumption, education, season, functional
capacity,marital status, presenceof chronicdisease anduseof sleep
medication.
Results: Mean total PA, expressed in milli-gravity(mg) units,
was slightlyhigher forwomen(20.3, SD:5.6) than formen(19.3, SD:
5.2, p< .01). Mean (SD) daily duration spent in sedentary behavior
and light and moderate-to-vigorous PA was 13.3 (1.5) h/d, 147.5
(31.5) minutes/d and 75.0 (25.5) minutes/d, respectively, among
women; and 13.8 (1.6) h/d, 140.5 (31.1) min/d and 71.5 (24.5)
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min/d, respectively, among men. Women spent on average 6.7 (SD:
1.1) h/d sleeping andmen6.6 (1.4) h/d. Across increasing categories
of age and BMI and in participantswith chronic disease and disabil-
ity, time spent in light andmoderate-to-vigorousPAwasdecreased.
Sedentary time increased with higher age and across higher strata
of BMI.
Conclusions: PA and sedentary behavior in the elderly dif-
fered by sex, age, BMI, prevalence of chronic disease and disability,
whereas there were no clear patterns for sleep. On average, our
participants spent up to 79.5% of their time awake being sedentary
and 7-8% in moderate-to-vigorous PA. Replacing sedentary behav-
ior with light PA would be a good starting point for those with the
lowest level of PA.
http://dx.doi.org/10.1016/j.maturitas.2017.06.012
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Introduction: Discrepancies between age-dependent beneﬁts
of Menopausal Hormone Therapy (MHT) for control of menopause
symptoms and the information reaching women concerned have
been subject of recurrent debate. Apparently women are mostly
misinformed and deprived of appropriate treatments. The present
study used the Health Belief Model (HBM) to explore factors inﬂu-
encing health behaviour e.g. perceived susceptibility, severity, risk
and beneﬁts, barriers and need for medication.
Aim: To assess menopause symptoms in women aged 40-60,
attitude to the transition and treatment of bother
Methods: An internet survey offered to 115 random women in
urban Zuid-Holland covered aspects of menopause, possible treat-
ments and the Greene Climacteric Scale (GCS) to screen symptoms.
Results: 85 women met inclusion criteria. Average age was 51
yrs, 57%hadnormalBMI, 18% smoked, 62%were employed. 81%had
bothersome symptoms (av.20.4; SD13.4) limiting social function-
ing andwork. 77% claim to bewell informed aboutmenopause, 24%
expect a positive experience, 57% expect no control over associated
changes. 64% had no treatment. 45% ﬁnd treatment unnecessary.
89% knew efﬁcacy of MHT, 23% knew beneﬁts and 40% knew risks.
For 48% risks of MHT outweigh beneﬁts. 69% ﬁnd homeopathic
remedies less harmful than MHT
Conclusion: Awareness of presence and impact of menopause
symptoms on work and social life seemed insufﬁcient. Women’s
attitude toward menopause was negative and determined by lack
of accurate knowledge, negative expectations and feelingof no con-
trol. Misinformation, expected self-limiting course and perceived
risk to beneﬁt balance constitute barriers limiting search for
effective help. Despite presence of susceptibility and severity of
symptoms decisions about treatments are absent or insufﬁciently
deliberated. Further study and more concerted efforts to bridge
knowledge gaps andhighlight beneﬁts of appropriatemanagement
of the menopause transition are needed.
http://dx.doi.org/10.1016/j.maturitas.2017.06.013
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Women with VVA often suffer from associated comorbidi-
ties, leading to increased utilization of healthcare resources. To
determine if treating VVA leads to savings in costs, we under-
took a retrospective analysis of the US claims-based MarketScan
®
Research Database.
We identiﬁed a cohort suffering from VVA and an age matched
control cohort.AdiagnosisofVVA is associatedwitha30.75%higher
increase in median costs compared to the control cohort due to an
increase in medication use, comorbidities and resource utilization,
many of which are associated with VVA.
We then split the VVA cohort in those treated vs. untreated.
Despite a 38% increase in medication costs, not treating VVA
patients resulted in a 10.27% higher relative increase in overall
median costs compared to the untreated VVA cohort. Although
these costswere speciﬁc to theUShealthcare system,more than2/3
of the top 30 events with the greatest difference in improvement
from baseline in the treated vs. untreated cohort were biologically
plausibly related to VVA treatment (urinary infection, frequency,
dysuria, cervical screening, cystocele, etc.) and would lead to cost
savings in any healthcare system.
We also looked if treatment with oestrogens or ospemifene
made a difference. Although medication costs doubled in the
ospemifene cohort (cf.with 37% increase for oestrogen), the greater
reduction in this cohort in comorbidities and resource utilizations
meant that therewas no difference in cost savings between the two
cohorts. Among the comorbidities and resource utilizations that
showed the highest decrease in the treatment cohorts compared
to no treatment, 20 of the top 30 were the same in both treatment
cohorts but with greater reductions in the ospemifene cohort.
In VVA patients with a history of breast cancer, non-treatment
resulted in a 40.84% higher relative increase in median costs vs. no
treatment due to a lower increase in costs for co-morbidities and
resource utilizations.
http://dx.doi.org/10.1016/j.maturitas.2017.06.014
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Introduction: Obesity is pandemic. Yet, the success of most
weight loss programs is poor.
The aim of the study was to assess illness perception in
overweight/obese people and its impact on bio-functional age
